Fluorometric measurement of reverse transcriptase activity with 4′,6-diamidino-2-phenylindole (DAPI): SJ Chavan and HJ Prochaska, Molecular Pharmacology & Therapeutics Program, Memorial Sloan-Kettering Cancer Center, New York, New York 10021
Volume:
26
Year:
1995
Language:
english
Pages:
1
DOI:
10.1016/0166-3542(95)94746-o
File:
PDF, 69 KB
english, 1995